Concepedia

Charles Dolladille

CD

23

Publications

1.9K

Citations

19

H-Index

2019

Active since

Affiliations

Université de Caen Normandie(Current)

Inserm

Centre Hospitalier Universitaire de Caen Normandie

Normandie Université

Sorbonne Université

Charles Dolladille is an author at Université de Caen Normandie specializing in medicine, pharmacotherapy, and cardiovascular disease.

ORCID

Top concepts

Publications per year

2019–2025

23

Publications

23

Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer

Charles Dolladille, Stéphane Éderhy, Marion Sassier et al. · JAMA Oncology · 2020 · 545 citations · Full text

Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines

Joachim Alexandre, Jennifer Cautela, Stéphane Éderhy et al. · Journal of the American Heart Association · 2020 · 283 citations · Full text

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Michele Fusaroli, Francesco Salvo, Bernard Bégaud et al. · Drug Safety · 2024 · 213 citations · Full text

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Michele Fusaroli, Francesco Salvo, Bernard Bégaud et al. · Drug Safety · 2024 · 142 citations · Full text

Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database

Lee S. Nguyen, Leslie T. Cooper, Mathieu Kernéis et al. · Nature Communications · 2022 · 124 citations · Full text

, , +19

Rows per page

1–5 of 23